Company Tagline
One Network. Multiple Pathways. The only global early-phase provider for FIH & clinical pharmacology in AU, USA & UK.
Industry Category
Business Keywords
Company Description
Nucleus Network stands as a leading global provider dedicated to early-phase clinical trials, operating seamlessly across Australia, the USA, and the UK. With a strong focus on accelerating new medicines, Nucleus Network offers sponsors unparalleled access to three major regulatory markets through a single, reliable partner. The company has a rich history, marked by the successful completion of over 2,500 early-phase studies and 1,500 First in Human trials spanning three decades.
Known for expertly managing intricate and adaptive designs, Nucleus Network is backed by robust scientific leadership and proven operational capabilities. Beyond its First in Human expertise, the company excels in conducting a comprehensive range of clinical pharmacology studies, ensuring sponsors benefit from depth, consistency, and extensive participant access. Nucleus Network's primary address is Level 5, Burnet Tower, 89 Commercial Road, Melbourne, Victoria 3004, AU, with additional locations at 1000 Westgate Dr, Suite 149, St Paul, Minnesota 55114, US; 300c Herston Rd, Herston, Queensland 4006, AU; and 44 Cumberland Avenue, London, England NW10 7EW, GB.
Nucleus Network’s unified global network delivers powerful solutions for advancing medical research. Operating with a commitment to excellence, Nucleus Network is dedicated to pushing the boundaries of early-phase clinical research. Nucleus Network is currently updating its offerings and services, ensuring cutting-edge solutions are available for all partners. We invite the manager of Nucleus Network to create a customized and exclusive company showcase and product listing on our platform.
Nucleus Network est un fournisseur mondial de premier plan dédié aux essais cliniques de phase précoce, opérant de manière transparente en Australie, aux États-Unis et au Royaume-Uni. En mettant fortement l'accent sur l'accélération de nouveaux médicaments, Nucleus Network offre aux sponsors un accès inégalé à trois principaux marchés réglementaires grâce à un partenaire unique et fiable. L'entreprise a une riche histoire, marquée par la réalisation réussie de plus de 2 500 études de phase précoce et de 1 500 essais de première administration à l'homme sur trois décennies.
Reconnu pour sa gestion experte de conceptions complexes et adaptatives, Nucleus Network s'appuie sur un leadership scientifique solide et des capacités opérationnelles éprouvées. Au-delà de son expertise en matière de première administration à l'homme, l'entreprise excelle dans la réalisation d'une gamme complète d'études de pharmacologie clinique, garantissant aux sponsors de bénéficier de la profondeur, de la cohérence et d'un accès étendu aux participants. L'adresse principale de Nucleus Network est Level 5, Burnet Tower, 89 Commercial Road, Melbourne, Victoria 3004, AU, avec des emplacements supplémentaires à 1000 Westgate Dr, Suite 149, St Paul, Minnesota 55114, US ; 300c Herston Rd, Herston, Queensland 4006, AU ; et 44 Cumberland Avenue, Londres, Angleterre NW10 7EW, GB.
Le réseau mondial unifié de Nucleus Network fournit des solutions puissantes pour faire progresser la recherche médicale. Opérant avec un engagement envers l'excellence, Nucleus Network se consacre à repousser les limites de la recherche clinique de phase précoce. Nucleus Network met actuellement à jour ses offres et services, garantissant que des solutions de pointe sont disponibles pour tous les partenaires. Nous invitons le responsable de Nucleus Network à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Nucleus Network with 3 companies in Research
| Comparison Field |
Nucleus NetworkMain Company |
ZenosisView Profile |
JCPR | Jordan Center...View Profile |
Scientia Clinical Re...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 1999 | 2015 |
|
Company Size
|
— | 2-10 | 51-200 | 51-200 |
|
City
|
Melbourne, Victoria | Dundee Technology Park, Scotland | Amman, Amman | Randwick, NSW |
|
Country
|
Australia | Scotland | Jordan | Australia |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Clinical Trials
Early Phase Research
Pharmacology Studies
First in Human Trials
Drug Development
Medical Research
Pharmacokinetics
Pharmacodynamics
Australian Clinical Trials
Early Phase Clinical Research
Phase I Clinical Trials
First in Human Studies
|
7 Total
7 Unique
Unique Skills:
Drug Safety
E-Learning
Good Manufacturing Process
Pharmaceutical
Pharmacovigilance
Regulatory affairs
+1
|
12 Total
12 Unique
Unique Skills:
Analysis
Bio-Analysis
Bioavailability
Bioequivalence
Biostudies
Clinical research
+6
|
6 Total
6 Unique
Unique Skills:
Bioavailability
Bioequivalence
Early Phase Clinical Trials
Oncology
Phase 1 Clinical Trials
Safety & Efficacy Studies
|
4
Total Companies1999
Oldest Founded3
Countries35
Unique SkillsSimilar Companies
Other organizations in the same industry
Global Entrepreneurship Monitor
ResearchThe world's foremost study of entrepreneurship. No research project analyzes entrepreneurship at the...
Alternative Company Names
This company is also known as